1-5 of 5
Keywords: Interferon-α
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1996) 19 (3): 214–219.
Published Online: 12 May 2009
... with metastatic disease (palliative) surgery may be indicated, too. (Chemo-) Embolization should to be considered for liver metastases causing severe local symptoms. Recently, biotherapy with somatostatins or interferon-α has revolutionized the treatment of metastatic neuroendocrine tumor disease...
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1996) 19 (3): 226–230.
Published Online: 12 May 2009
...-IIa we suggest PUVA alone or in combination with retinoids as the first-line therapy. If there is disease progression, interferon-α or methotrexate shall be added. CTCL cases in stage lib can be treated with PUVA combined with interferon-α and soft X-ray radiation (6-8 ×200 cGy, 50 kV twice/week...
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1994) 17 (3): 263–269.
Published Online: 11 May 2009
...I. Funke; E. Späth-Schwalbe; G. Stohlmann; O. Prümmer; H. Gallati; H. Schrezenmeier; F. Porzsolt Background: In advanced renal cell cancer (RCC) interleukin-2 (IL-2) and interferon-α (IFN-α) have shown modest clinical activity as single agents, substantial toxicity being associated with IL-2...
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1991) 14 (2): 178–180.
Published Online: 28 April 2009
...H. Hausmaninger; B. Oentrich; K. Nachbaur; D. Niederwieser; R. Haidinger; C. Huber Im Rahmen einer Phase-2-Studie wird versucht, eine Ansprechrate von 60–80%, die bei Patienten mit metastasierenden gastrointestinalen Karzinomen mit der Kombination 5-Fluorouracil und Interferon-α erreicht wurde, zu...
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1988) 11 (4): 192–196.
Published Online: 27 April 2009
...H. Ludwig; W. Scheithauer; I. Kührer; R. Kuzmits; G. Gisslinger; W. Linkesch; Ch. Zielinski; E. Fritz Natürliches Leukozyteninterferon und rekombinantes Interferon-α-2 bewirken beim multiplen Myelom Remissionsraten zwischen 10 und 20%, wobei nicht chemotherapeutisch vorbehandelte Patienten höhere...